Esophageal squamous cell carcinoma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The study group comprised patients who were reported at Panel Discussion 18 - Treatment Strategy After Endoscopic Resection of MM/SM1 Squamous-cell Carcinoma of the Esophagus - of the 93rd Annual Meeting of the Japan Gastroesophageal Endoscopy Society on May 12, 2017 (Osaka International Convention Center). In other words, we studied patients who underwent endoscopic resection of MM/SM1 squamous-cell carcinoma of the esophagus between August 1, 1992 and April 30, 2016.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Clinicopathological characteristics 2. Description of additional treatment 3. Overall survival rates, relapse-free survival rates, and disease-specific survival rates (for all patients and according to invasion depth and the presence or absence of additional treatment) 4. Risk factors for recurrence 5. Clinical course of patients with recurrence | — |
Countries
Japan
Contacts
Kitasato University School of Medicine Department of Gastroenterology